Evommune, Inc. (EVMN) Market Cap
- 2026-09-03: Market Cap $436.23M.
- 2026-08-04: Market Cap $475.79M.
- 2026-06-30: Market Cap $482.18M.
- 2026-05-05: Market Cap $870.2M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2025-12-10 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $436.23M |
| 2026-08-04 | $475.79M |
| 2026-06-30 | $482.18M |
| 2026-05-05 | $870.2M |
| 2026-03-31 | $828.06M |
| 2026-03-03 | $860.12M |
| 2025-12-31 | $539.69M |
| 2025-12-10 | $618.19M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |